DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more


Nutrilib.com
A comprihensive source of nutritional information

Diagnosis and Follow-up of Patients With Subclinical Hypothyroidism

Information source: Zhejiang University
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Congenital Hypothyroidism; L-Thyroxine; Follow-Up

Phase: N/A

Status: Completed

Sponsored by: Zhejiang University

Official(s) and/or principal investigator(s):
zhengyan Zhao, doctor, Study Director, Affiliation: Pediatric Society of the Chinese Medical Association

Summary

Long term follow-up of the patients with delayed TSH elevation or subclinical hypothyroidism has been seldom reported. The purpose of this study was to explore the diagnostic criteria for subclinical hypothyroidism and the initial dosage of L-thyroxine through long-term follow up for infants with subclinical hypothyroidism ,and evaluate the curative effect.

Clinical Details

Study design: Screening, Longitudinal, Defined Population, Prospective Study

Detailed description: Long term follow-up of the patients with delayed TSH elevation or subclinical hypothyroidism has been seldom reported. The purpose of this study was to explore the diagnostic criteria for subclinical hypothyroidism and the initial dosage of L-thyroxine through long-term follow up for infants with hyperthyrotropinemia,and evaluate the curative effect. All live-born neonates in province took part in the screening program from October, 1999 to September ,2006. Laboratory tests are performed as a time resolved fluoro-immunoassay (TRFIA). TSH is measured with a cut-off > 9 mU/L. The diagnostic standard for subclinical hypothyroidism was: TSH ≥ 20 mU/L, T3 and T4 normal or low-normal ,or TSH > 5. 6 mU/L and < 20 mU/L on initial determination and on follow-up or TSH levels increase on follow-up and/or gradually declining T4 levels. L-Thyroxine was administered for substitution therapy. After 2 years therapy,allround evaluation was performed. Compare the correlation to effects with different level of TSH、starting time of therapy and environment. Compare the effects between subclinical、temporary and permanent hypothyroidism.

Eligibility

Minimum age: N/A. Maximum age: 5 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- The diagnostic standard for manifest hypothyroidism and subclinical hypothyroidism was

defined as follows:

- Hypothyroidism - TSH > 40 mU/L and T3 and T4 below the reference range or TSH >

40 mU/L, T3 normal and T4 below the reference range [2]

- Subclinical hypothyroidism - TSH ≥ 20 mU/L, T3 and T4 normal or low-normal or TSH

> 5. 6 mU/L and < 20 mU/L on initial determination and on follow-up or TSH levels increase on follow-up and/or gradually declining T4 levels.

Locations and Contacts

Additional Information

Starting date: October 1999
Ending date: September 2006
Last updated: July 5, 2007

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008